Feeds:
Posts
Comments

Archive for the ‘Market research’ Category

By Ronald H. Coelyn, Founding Managing Partner – The Coelyn Group

I recently read an article in a major newspaper purporting to give advice about recruiting executive talent in today’s extremely challenging economic climate.  Frankly, the advice given by these so-called experts in both print and broadcast media is unsubstantiated nonsense and very misleading – giving the distinct impression that their stories represent the “real” world.  It doesn’t work that way!

Myth 1 – Hiring only the “employed” in the current economy: The theory behind this statement is that unemployed executives are not as qualified as those who are employed.  This tried and “true” belief is untrue – most especially today.  In more than 23-years of executive search consulting I’ve never seen so many exemplary candidates become available through no fault of their own.  My firm would and has presented “A” player candidates who were currently between assignments.

Myth 2 – Age matters; don’t hire candidates in the third third of their career: This statement basically says that executives have about a 45-year career timeframe (from age 21 to age 65) prior to retirement.  But in reality, health, energy, passion and desire are the key components in evaluating a candidate of any age. More to the point, recent studies have shown that the average stay for a senior level executive is 2.3 years (reflecting the challenges of senior management, M&A activity, etc.). So hiring someone with perhaps 15 or more years left in their career, or even 3-4 years, should never be a problem.  And I would seriously consider candidates beyond age 65 assuming they have the aforementioned energy, etc.

Myth 3 – Wealthy executives don’t want to work anymore: they can’t be motivated: Clearly, this is an individual decision and many executives who have become independently wealthy elect to retire.  But I have personally come to know a great many such fortunate executives who have decided to continue their business careers. They just love the process, the thrill of competition and the realization that their contributions are truly important to society.

A perfect example is the venture capitalists.  As a group these creative leaders have often amassed considerable wealth and yet they “remain steadfastly in the game.”  And notwithstanding the current economic crisis which is impacting their sector we all know that they will come back strong, albeit perhaps with a different model for conducting business – but raise new funds and invest they will.  Of that, you can be certain.

Ronald H. Coelyn – Founding Managing Partner, The Coelyn Group
Ron is the Founding Partner of The Coelyn Group which specializes in Healthcare and Life Sciences. For the past 17 of his 30-year career, he has been active in these industries as a senior executive officer and, most recently, as an executive search consultant (both as a Founder of this Firm and as a Partner in the prestigious international executive search firm SpencerStuart). His executive search consulting practice spans engagements ranging from Chairman of The Board, Members of The Board of Directors, President & Chief Executive Officer to a variety of Vice Presidential and other senior level executive positions.

Read Full Post »

Here is a good reflective article from CNN on the art of mergers – and it´s possible pitfalls.

“(Fortune Magazine) — David Crane, CEO of NRG Energy and a father of five, was standing in a stubby cornfield in Bucks County, Pa., one windy evening last October when his BlackBerry began to stir. He checked his in-box, but he didn’t respond, not right away. It was Sunday night, and he was on an outing with his family, waiting in line for a Halloween hayride. Nor did he respond an hour later on his way to the Amtrak station to catch a train to Washington, D.C. How could he, when he drives a Mini Cooper with a stick shift? You need both hands to manage a car like that. So it wasn’t until after nine at night, having found a quiet corner of the waiting room behind a Dunkin’ Donuts kiosk, that Crane finally got around to calling back John Rowe.

Rowe, CEO of Exelon Corp. (EXC, Fortune 500), picked up Crane’s call at his big-windowed aerie in Chicago’s Chase Tower, 54 stories above the Loop. Rowe told Crane that his board had met that afternoon, and he had some news: Exelon, the country’s biggest electric utility, was hereby offering to buy NRG (NRG, Fortune 500), the country’s fastest-growing independent electricity merchant — it sells wholesale power to utilities — for stock in a deal worth $6.2 billion. Term sheet to follow, press release within the hour. “Offer” was a euphemism; this was a hostile act.

Crane was stunned, less by Rowe’s uninvited bid (his lust for NRG was no secret) than by his choosing to publicize it instantly. Protocol dictates that a classic bear hug, as the M&A world defines the ritual, begin with a warm embrace, in private, with an eye toward achieving mutual consent. Rowe wasn’t even pretending to be nice. Crane could imagine why. NRG was secretly pursuing two deals of its own with Houston-based power companies: one code-named Doris, for Dynegy (DYN), the other Rodeo, for Reliant. Either would create regulatory obstacles that could block Exelon. Somehow Rowe had gotten wind of them. Neither was imminent, Crane says now (“He had a lot more time”), but Rowe didn’t know that.

Their conversation lasted only a few minutes. Crane asked Rowe if he had his debt financing in place. Both men understood that a change of control would trigger an immediate requirement to pay down $8.5 billion in NRG loans. “Not yet,” said Rowe, “but we’re working on it.” Crane wanted nothing to do with this deal: not with Rowe, whom he barely knew; not with Exelon, which he views as stodgy, bureaucratic, and otherwise “ill suited” to run an entrepreneurial enterprise like NRG without “suffocating” it; and definitely not at that price, which he would soon be describing to anyone who would listen as tantamount to “stealing the company.” Nevertheless, he tried to be civil as he concluded the call, promising Rowe, “We’ll give this serious consideration.”

So much for his scheduled trip to Washington. Crane called Jonathan Baliff, NRG’s M&A specialist, and reached him at home. “You’re not gonna believe this,” he said, still not quite believing it himself. “John Rowe just called to wish me a happy Halloween.”

Click here for the whole article.

Read Full Post »

Here is a story I picked up at DowJones VentureSource;

“Dow Jones VentureSource is reporting today that Q2 of this year was “one of the worst” ever for venture capital backed firms, in terms of liquidity, since early 2003. According to Dow Jones, there was only $2.8 billion in exits for the quarter, including both mergers and acquisitions and IPOs, down 57% from last year’s numbers. Dow Jones said there was $2.57 billion in mergers and acquisitions of 67 companies in Q2, down from $6.48B and 89 transactions in Q2 of 2008. The three venture-backed IPOs on the market raised $232M. In terms of valuation, VentureSource reported the median amount paid for a venture-backed company in Q2 was almost $22M, down from $41M from the comparable period in 2008″


Read Full Post »

Good news are starting to come across from market indicators. The economy is slowly starting to turn its heavy pessimism to a optimistic, normal belief of opportunity. Looking at these indicators on IPO filings, there are plenaty of opportunities on the horizon.

Here ar some good news posted by Wall Street Journal.

“The pace of new stock offerings perked up this spring after a cold winter, but the market for new issues still has a long way to go before a real recovery.

The story was the same in every corner of the world. At best, there was a pickup in issuance in the second quarter of 2009 from the first quarter, but there was nowhere near the levels of a year earlier.

World-wide, 78 companies raised $10.6 billion in initial public offerings of stock in the second quarter, up from 54 deals that raised just $1.3 billion in the first three months of 2009, according to data from Dealogic, which tracks new issues. But in the second quarter of 2008, 243 new public companies sold $33.4 billion of shares, by Dealogic’s count. All data exclude real-estate investment trusts and empty shell companies known as special-purpose acquisition companies, or SPACs.

If comparisons with last year aren’t sobering enough, consider this: In the second quarter of 2007, 469 companies raised a total of $88.2 billion — six times the number and more than eight times the dollar volume of the latest three months.

“In terms of volume of issuance, let’s face it, we’re still in the very early innings of recovery,” says Kevin Willsey, head of equity capital markets for the Americas at J.P. Morgan Chase & Co.

U.S. pricings in the latest quarter totaled 10, valued at $1.3 billion, compared with 11 deals that raised $4.2 billion in the 2008 period. Latin America and India each had one IPO for the second quarter, while Russia and Australia had none.

The largest offering in the world during the second quarter was the $4.27 billion raised on the Bovespa stock exchange by VisaNet, the Brazilian affiliate of credit-card network Visa Inc.

China had 13 IPOs in the second quarter that raised a combined $2.9 billion, compared with 20 that raised $2.3 billion a year ago; Europe had 10 deals totaling just $209 million, compared with 79 that raised $12.1 billion.

Still, bankers appear more optimistic now about the IPO market than at any time since last fall, with many saying there could be a stronger pickup in issuance in the second part of this year.

U.S. IPOs have performed well on their debuts this year. The May offering of OpenTable Inc. generated the best first-day performance since late 2007, before the stock-market meltdown. The company, which raised $60 million in its offering, rose 59% on its first day of trading.

The outlook for the IPO market depends on whether there are nasty surprises in second-quarter earnings reports, which will start arriving by the middle of this month, stable prices in the broader stock market and continued hopes for economic recovery.”

In this articl, Lynn cowan closes by saying:

“More deals later in the year would play into historical buying patterns by large institutions such as mutual funds and hedge funds, says Joe Castle, head of U.S. equities syndicate at Barclays Capital. “Fall is a popular time to buy IPOs,” he says, “because it positions portfolios with high-growth companies for the following calendar year and boosts performance for the current year if they trade well initially.”

Despite glimmers of hope in some areas of the world, like the U.S., bankers and investors alike are aware things could suddenly take a turn for the worse.

“We don’t see firms storming the gates to launch into the IPO market right now,” says David DiPietro, president of boutique investment bank Signal Hill in Baltimore. “We probably need to see another quarter of solid earnings from a broad base of companies.”

To read the full article, click here.

Read Full Post »

As Facebook secured some investments earlier this year, and invested it towards international growth, the latest news spark renewed IPO rumors.

Of course, no one knows, but the hiring of a CFO from a larger corporation is nothing you do unless you have greater plans. First and foremost, it costs you a bunch of money, secondly, the demands this person has on you by his experience will force the structure needed upon you.

The biggest challenge remains though – to create profitability.

Here is a quoted article from BusinessWeek.

“In April, when Facebook announced the departure of Chief Financial Officer Gideon Yu, the social network said it would look for a replacement “with public company experience.” Facebook found what it was seeking in David Ebersman, a 15-year veteran of biotech pioneer Genentech (DNA).

“David [Ebersman] worked at one of the most innovative and respected [companies] in the world, so he brings a lot to the table when it comes to our efforts to build a lasting, important company,” Facebook spokesman Larry Yu says of the appointment, announced on June 29.

Ebersman’s appointment keeps alive speculation over whether and how soon the world’s biggest social network is headed for an initial public share sale. “We have no plans to go public,” says spokesman Larry Yu. Facebook CEO Mark Zuckerberg was quoted in May saying an IPO remains “a few years out.”

Ebersman, 38, served as Genentech’s CFO for the four years leading up to its $46.8 billion sale to drug giant Roche Holding (ROG) in May. In Facebook’s press release, CEO Mark Zuckerberg noted that under Ebersman, Genentech’s revenue tripled. Zuckerberg envisions high growth for his company as well, saying sales will rise 70% this year. (eMarketer has projected that Facebook’s revenue will grow 20% this year, to $300 million.)”

Read the full article here.

Read Full Post »

« Newer Posts - Older Posts »